FP3.F
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
5 more panels on FP3.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 13, 26 | DAGGS NICOLE J Officer |
SELL | 4.93K | $458.86K | Direct |
| Mar 9, 26 | CREWS TERRELL KIRK II Officer |
CONVERSION | 19.67K | $786.60K | Direct |
| Mar 9, 26 | MAY JAMES MICHAEL Officer and Treasurer |
SELL | 7.16K | $646.42K | Direct |
| Mar 9, 26 | LEMASNEY MARK Officer |
SELL | 3.85K | $347.09K | Direct |
| Mar 9, 26 | CREWS TERRELL KIRK II Officer |
SELL | 19.67K | $1.78M | Direct |
| Feb 17, 26 | REAGAN RONALD R Officer |
SELL | 5.08K | $482.50K | Direct |
| Feb 12, 26 | PORGES DAVID L Director |
STOCK | 2.13K | $0 | Direct |
| Feb 12, 26 | CAMAREN JAMES LAWRENCE Director |
STOCK | 2.13K | $0 | Direct |
| Feb 12, 26 | GURSAHANEY NAREN K Director |
STOCK | 2.13K | $0 | Direct |
| Feb 12, 26 | SIEVING CHARLES E Officer |
STOCK | 38.96K | $0 | Direct |
| Feb 12, 26 | PIMENTEL ARMANDO JR. Officer and Director |
STOCK | 16.66K | $0 | Direct |
| Feb 12, 26 | HACHIGIAN KIRK S Director |
STOCK | 2.13K | $0 | Direct |
| Feb 12, 26 | STALL JOHN A Director |
STOCK | 2.13K | $0 | Direct |
| Feb 12, 26 | HENRY MARIA G Director |
STOCK | 2.13K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAMAREN JAMES LAWRENCE |
Director | 166.45K | Stock Award(Grant) |
COFFEY ROBERT |
Officer | 55.96K | Stock Award(Grant) |
CREWS TERRELL KIRK II |
Officer | 77.15K | Conversion of Exercise of derivative security |
DUNNE MICHAEL |
Chief Financial Officer | 71.91K | Stock Award(Grant) |
HACHIGIAN KIRK S |
Director | 102.49K | Stock Award(Grant) |
KETCHUM JOHN W. |
Chief Executive Officer | 412.60K | Stock Award(Grant) |
KUJAWA REBECCA J. |
Officer | 204.10K | Stock Award(Grant) |
LANE AMY BETH |
Director | 53.88K | Stock Award(Grant) |
PIMENTEL ARMANDO JR. |
Officer and Director | 182.83K | Stock Award(Grant) |
SIEVING CHARLES E |
Officer | 201.54K | Stock Award(Grant) |
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $27.41B | $24.75B | $28.11B | $20.96B | +10.7% |
| Operating revenue | $27.41B | $24.75B | $28.11B | $20.96B | +10.7% |
| Cost of revenue | $10.34B | $9.89B | $10.14B | $10.82B | +4.6% |
| Gross profit | $17.07B | $14.87B | $17.98B | $10.14B | +14.8% |
| Total operating expense | $9.05B | $7.74B | $8.14B | $6.58B | +16.9% |
| Operating income | $8.02B | $7.13B | $9.83B | $3.56B | +12.5% |
| Net interest income | -$4.57B | -$2.23B | -$3.32B | -$585.00M | -104.6% |
| Pre-tax income | $4.53B | $6.04B | $7.29B | $3.83B | -25.0% |
| Tax provision | -$802.00M | $339.00M | $1.01B | $586.00M | -336.6% |
| Net income | $6.83B | $6.95B | $7.31B | $4.15B | -1.6% |
| Net income to common | $6.83B | $6.95B | $7.31B | $4.15B | -1.6% |
| Basic EPS | 3.31 | 3.38 | 3.61 | 2.10 | -2.1% |
| Diluted EPS | 3.30 | 3.37 | 3.60 | 2.10 | -2.1% |
| EBIT | $9.10B | $8.27B | $10.61B | $4.42B | +10.0% |
| EBITDA | $16.04B | $14.03B | $16.76B | $9.21B | +14.3% |
| Basic shares | 2.06B | 2.05B | 2.03B | 1.97B | +0.6% |
| Diluted shares | 2.07B | 2.06B | 2.03B | 1.98B | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.81B | $1.49B | $2.69B | $1.60B | +89.1% |
| Cash & short-term investments | $2.81B | $1.49B | $2.69B | $1.60B | +89.1% |
| Accounts receivable | $4.02B | $3.34B | $3.61B | $4.35B | +20.4% |
| Inventory | $2.42B | $2.21B | $2.11B | $1.93B | +9.3% |
| Total current assets | $13.58B | $11.95B | $15.36B | $13.49B | +13.7% |
| Property, plant & equipment | $156.20B | $138.85B | $125.78B | $111.06B | +12.5% |
| Goodwill & intangibles | $6.62B | $6.58B | $6.78B | $5.61B | +0.5% |
| Total assets | $212.72B | $190.14B | $177.49B | $158.94B | +11.9% |
| Total current liabilities | $22.82B | $25.36B | $27.96B | $26.70B | -10.0% |
| Current debt | $6.06B | $9.95B | $11.81B | $9.71B | -39.1% |
| Long-term debt | $89.56B | $72.39B | $61.41B | $55.26B | +23.7% |
| Total debt | $95.62B | $82.33B | $73.21B | $64.97B | +16.1% |
| Total liabilities | $146.24B | $129.28B | $118.47B | $109.50B | +13.1% |
| Retained earnings | $35.10B | $32.95B | $30.23B | $26.71B | +6.5% |
| Shareholder equity | $54.61B | $50.10B | $47.47B | $39.23B | +9.0% |
| Working capital | -$9.23B | -$13.40B | -$12.60B | -$13.21B | +31.1% |
| Net tangible assets | $47.99B | $43.52B | $40.69B | $33.62B | +10.3% |
| Shares issued | 2.08B | 2.06B | 2.05B | 1.99B | +1.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $5.33B | $5.70B | $6.28B | $3.25B | -6.4% |
| Depreciation & amortisation | $6.94B | $5.76B | $6.15B | $4.79B | +20.5% |
| Change in working capital | -$373.00M | $160.00M | -$1.39B | $412.00M | -333.1% |
| Operating cash flow | $12.48B | $13.26B | $11.30B | $8.26B | -5.8% |
| Capital expenditure | -$9.27B | -$8.51B | -$9.55B | -$9.74B | -8.9% |
| Investing cash flow | -$23.86B | -$22.26B | -$23.47B | -$18.36B | -7.2% |
| Dividends paid | -$4.68B | -$4.24B | -$3.78B | -$3.35B | -10.5% |
| Financing cash flow | $12.98B | $7.00B | $12.15B | $12.23B | +85.4% |
| Free cash flow | $3.21B | $4.75B | $1.75B | -$1.48B | -32.3% |
| End cash position | $3.01B | $1.40B | $3.42B | $3.44B | +114.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $7.53B | $6.70B | $6.50B | $7.97B | $6.70B | — | +12.4% |
| Operating revenue | $7.53B | $6.70B | $6.50B | $7.97B | $6.70B | — | +12.4% |
| Cost of revenue | $2.83B | $2.75B | $2.77B | $2.83B | $2.40B | — | +3.0% |
| Gross profit | $4.70B | $3.95B | $3.73B | $5.13B | $4.30B | — | +19.0% |
| Total operating expense | $2.42B | $2.00B | $2.21B | $2.75B | $2.40B | — | +21.3% |
| Operating income | $2.28B | $1.95B | $1.52B | $2.38B | $1.89B | — | +16.7% |
| Net interest income | -$487.00M | -$1.29B | -$585.00M | -$1.15B | -$1.06B | — | +62.2% |
| Pre-tax income | $2.54B | $1.20B | $1.32B | $1.89B | $1.38B | — | +111.7% |
| Tax provision | -$84.00M | -$489.00M | $225.00M | -$250.00M | -$256.00M | — | +82.8% |
| Net income | $3.14B | $2.18B | $1.53B | $2.44B | $2.03B | — | +44.1% |
| Net income to common | $3.14B | $2.18B | $1.53B | $2.44B | $2.03B | — | +44.1% |
| Basic EPS | 1.51 | 1.05 | 0.74 | — | 0.99 | 0.41 | +43.8% |
| Diluted EPS | 1.50 | 1.04 | 0.73 | — | 0.98 | 0.40 | +44.2% |
| EBIT | $3.02B | $2.49B | $1.90B | $3.04B | $2.44B | — | +21.7% |
| EBITDA | $4.90B | $3.95B | $3.62B | $5.23B | $4.30B | — | +24.1% |
| Basic shares | 2.08B | 2.08B | 2.08B | — | 2.06B | 2.06B | +0.0% |
| Diluted shares | 2.09B | 2.09B | 2.09B | — | 2.06B | 2.06B | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.87B | $2.00B | $2.81B | $2.39B | $1.73B | +43.4% |
| Cash & short-term investments | $2.87B | $2.00B | $2.81B | $2.39B | $1.73B | +43.4% |
| Accounts receivable | $4.71B | $4.13B | $4.02B | $3.94B | $3.87B | +14.0% |
| Inventory | $2.62B | $2.58B | $2.42B | $2.43B | $2.21B | +1.5% |
| Total current assets | $15.47B | $13.86B | $13.58B | $12.67B | $12.49B | +11.6% |
| Property, plant & equipment | $170.45B | $162.36B | $156.20B | $150.04B | $145.74B | +5.0% |
| Goodwill & intangibles | $5.15B | $5.15B | $6.62B | $4.85B | $4.87B | +0.0% |
| Total assets | $232.81B | $221.42B | $212.72B | $204.35B | $198.83B | +5.1% |
| Total current liabilities | $28.97B | $25.57B | $22.82B | $22.91B | $23.05B | +13.3% |
| Current debt | $11.41B | $10.46B | $6.06B | $8.95B | $10.50B | +9.1% |
| Long-term debt | $98.79B | $93.95B | $89.56B | $84.17B | $82.69B | +5.2% |
| Total debt | $110.20B | $104.40B | $95.62B | $93.12B | $93.19B | +5.5% |
| Total liabilities | $164.65B | $154.79B | $146.24B | $139.76B | $137.90B | +6.4% |
| Retained earnings | $37.83B | $35.98B | $35.10B | $34.75B | $33.48B | +5.1% |
| Shareholder equity | $57.13B | $55.22B | $54.61B | $54.18B | $50.80B | +3.4% |
| Working capital | -$13.51B | -$11.71B | -$9.23B | -$10.24B | -$10.55B | -15.3% |
| Net tangible assets | $51.97B | $50.07B | $47.99B | $49.33B | $45.93B | +3.8% |
| Shares issued | 2.09B | 2.09B | 2.08B | 2.08B | 2.06B | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.62B | $1.69B | $1.09B | $2.13B | $1.64B | +55.3% |
| Depreciation & amortisation | $1.88B | $1.46B | $1.72B | $2.19B | $1.86B | +28.3% |
| Change in working capital | $965.00M | -$590.00M | -$473.00M | $46.00M | $44.00M | +263.6% |
| Operating cash flow | $4.66B | $2.61B | $2.50B | $4.03B | $3.19B | +78.3% |
| Capital expenditure | -$2.86B | -$3.19B | -$2.22B | -$2.48B | -$2.07B | +10.6% |
| Investing cash flow | -$8.29B | -$10.82B | -$5.21B | -$5.11B | -$5.82B | +23.4% |
| Dividends paid | -$1.30B | -$1.30B | -$1.18B | -$1.17B | -$1.17B | +0.1% |
| Financing cash flow | $4.38B | $7.68B | $3.00B | $1.82B | $2.06B | -43.0% |
| Free cash flow | $1.80B | -$580.00M | $277.00M | $1.55B | $1.12B | +411.2% |
| End cash position | $3.22B | $2.48B | $3.01B | $2.71B | $1.98B | +30.2% |
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $9.17B | +15.2% |
| Next quarter | — | — | $7.97B | +22.6% |
| Current year | — | — | $31.03B | +13.2% |
| Next year | — | — | $34.63B | +11.6% |
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 27, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Jul 20, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Jul 13, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jul 7, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 17, 26 | Bernstein | INITIATED | — | Outperform |
| May 26, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 19, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 13, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 4, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Apr 27, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Apr 24, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.